Nuo Therapeutics, Inc. is a commercial stage medical device company that specializes in innovative biodynamic therapies aimed at enhancing healing processes. Their flagship product, Aurix®, is a biodynamic hematogel that leverages the patient's own platelets and plasma to promote healing. This approach not only focuses on improving patient outcomes but also addresses the broader health economic system by providing effective and efficient therapeutic solutions. Nuo Therapeutics is committed to advancing wound care through biologically relevant clinical solutions that demonstrate proven value in patient health.

The company emphasizes a vision of bold leadership and a commitment to exploring emerging opportunities within the healthcare landscape. By prioritizing the development of therapies that are both effective and economically beneficial, Nuo Therapeutics aims to redefine standards in wound care and healing. Their focus on harnessing the body's natural healing mechanisms through the use of autologous materials positions them at the forefront of medical device innovation, ultimately striving to improve patient care and health outcomes.

United States

Nuo Therapeutics, Inc. is a biomedical company that develops and commercializes individualized wound care therapies that harness a patient’s innate regenerative ability to stimulate wound healing.

The Company’s flagship product, Aurix is a biodynamic hematogel derived from the patient’s own platelets and plasma, which is used at the point-of-care to jumpstart the natural healing process in a broad range of chronic wounds, including diabetic foot ulcers, venous leg ulcers and pressure injuries.

Nuo Therapeutics

Company Details